Correlation Between Nuvectis Pharma and PepGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and PepGen, you can compare the effects of market volatilities on Nuvectis Pharma and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and PepGen.

Diversification Opportunities for Nuvectis Pharma and PepGen

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Nuvectis and PepGen is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and PepGen go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and PepGen

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 18.54 times less return on investment than PepGen. But when comparing it to its historical volatility, Nuvectis Pharma is 1.09 times less risky than PepGen. It trades about 0.0 of its potential returns per unit of risk. PepGen is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  634.00  in PepGen on September 2, 2024 and sell it today you would lose (129.00) from holding PepGen or give up 20.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  PepGen

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
PepGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nuvectis Pharma and PepGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and PepGen

The main advantage of trading using opposite Nuvectis Pharma and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.
The idea behind Nuvectis Pharma and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stocks Directory
Find actively traded stocks across global markets